Centessa Pharmaceuticals Plc ADR CNTA

$40.50 +0.32 (0.80%)

Valuation

Market cap
6,266,606,000
Revenue TTM
$15,000,000
Net income TTM
$-197,530,000
PE ratio
0.00
Forward PE
—
Profit margin
-1,316.87%
Debt to equity
0.23

Trading

Volume
11,330,400
Avg volume
1,996,130
Day's range
$40.00 – $40.56
Shares out
154,731,000
Stochastic %K
93%
Beta
1.11
Analysts
Sell
Price target
$42.40

Price

Company profile

Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, which is in Phase IIa clinical trial for the treatment of central disorders of hypersomnolence, including narcolepsy type 1 and 2, as well as idiopathic hypersomnia. It also engages...

Show more

Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, which is in Phase IIa clinical trial for the treatment of central disorders of hypersomnolence, including narcolepsy type 1 and 2, as well as idiopathic hypersomnia. It also engages in the development of ORX142 which is in Phase I clinical trial for the treatment of neurological and neurodegenerative disorders; ORX489 which is in Phase I clinical trial for the treatment of neuropsychiatric disorders; and LockBody, an early-stage immuno-oncology program technology platform. The company was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

Industry
Biotechnology
Sector
Healthcare
Website
https://centessa.com
Address
1 Ashley Road, 3rd Floor, Altrincham, United Kingdom

Latest news

Stocktwits

THE_TRADE Aug 5, 4:52 PM
$LLY $NVO $CNTA $CVS CVS Health (CVS) earnings Q2 2026 https://share.google/j9ebL116LBnNjI69u
0 replies
TalkMarkets Aug 5, 4:50 PM
Eli Lilly Stock Surges 6% After Q2 Earnings Beat Driven By Mounjaro, Zepbound $LLY Also Mentions: $NVO $CNTA $CVS https://talkmarkets.com/article/eli-lilly-stock-surges-6-after-q2-earnings-beat-driven-by-mounjaro-zepbound-1785948575
0 replies
TwongStocks Jun 17, 7:06 PM
$CNTA Equity Corporate Actions Alert #2026 - 416 Information Regarding the Merger of Centessa Pharmaceuticals plc (CNTA) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-416 At a special meeting held on June 12, 2026, the shareholders of Centessa Pharmaceuticals plc (CNTA) approved the proposed merger with Eli Lilly and Company. The merger is tentatively scheduled to close prior to the market open on June 24, 2026. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on June 23, 2026. If the merger closes as anticipated, the stock will remain halted on the day of closing (June 24th) and will be suspended effective June 25, 2026.
0 replies
Mergerbrief Jun 12, 11:54 AM
$CNTA / $LLY – Shareholder Vote CNTA
0 replies
theoptionsplug Jun 12, 5:15 AM
THINGS TO WATCH, FRIDAY, 6/12/2026 👁️ $SPCX.X $LLY $CNTA $KLAC $SPY
1 replies
OpenOutcrier Apr 29, 8:04 PM
RECAP 4/29 Unusual Puts: $CNTA Jul 35 P $BMNR Jun 15 P $ONDS Dec 6 P $CCJ May29 85 P $ONDS Jun 8 P $WMT May01 125 P Live Breaking trading news www.openoutcrier.com
0 replies
StocktwitsNews Apr 27, 6:02 PM
Eli Lilly’s Been On An Acquisition Spree This Year – Here’s A Look At Its Major Deals $LLY $CNTA https://stocktwits.com/news/equity/markets/eli-lilly-acquisition-spree-this-year-look-at-its-major-deals/cZBNxaDRePo
0 replies
DonCorleone77 Apr 13, 4:48 AM
$CNTA Centessa downgraded to Hold from Buy at Truist Truist analyst Danielle Brill downgraded Centessa (CNTA) to Hold from Buy with a $38 price target after Eli Lilly (LLY) announced an agreement to acquire the company for $38 per share in cash plus a non-transferable contingent value right worth up to $9 per share.
0 replies